ETF Holdings Breakdown of CSTL

Stock NameCastle Biosciences Inc
TickerCSTL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS14843C1053

News associated with CSTL

Wells Fargo & Company MN Buys 3,460 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
Wells Fargo & Company MN lifted its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 29.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,375 shares of the company’s stock after acquiring an additional 3,460 shares during the period. Wells […] - 2025-05-05 07:23:03
CANADA LIFE ASSURANCE Co Sells 2,506 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
CANADA LIFE ASSURANCE Co trimmed its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 19.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,713 shares of the company’s stock after selling 2,506 shares during the quarter. CANADA LIFE ASSURANCE Co’s holdings […] - 2025-05-01 08:40:55
LPL Financial LLC Sells 3,421 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
LPL Financial LLC decreased its position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 12.9% in the 4th quarter, Holdings Channel reports. The fund owned 23,043 shares of the company’s stock after selling 3,421 shares during the quarter. LPL Financial LLC’s holdings in Castle Biosciences were worth $614,000 as of its most […] - 2025-04-24 07:16:59
ExodusPoint Capital Management LP Sells 32,779 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
ExodusPoint Capital Management LP cut its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 74.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 11,484 shares of the company’s stock after selling 32,779 shares during the period. ExodusPoint Capital Management LP’s holdings in Castle Biosciences were […] - 2025-04-14 08:58:59
Corebridge Financial Inc. Sells 972 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
Corebridge Financial Inc. lessened its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 7.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 12,860 shares of the company’s stock after selling 972 shares during the quarter. Corebridge Financial Inc.’s holdings in Castle Biosciences […] - 2025-04-11 07:54:48
Brokerages Set Castle Biosciences, Inc. (NASDAQ:CSTL) PT at $38.75
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) has been given a consensus rating of “Buy” by the eight brokerages that are currently covering the company, Marketbeat Ratings reports. Eight analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have issued a report on the stock […] - 2025-04-10 06:07:07
Castle Biosciences, Inc. (NASDAQ:CSTL) Shares Bought by Sei Investments Co.
Sei Investments Co. lifted its stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 9.6% during the 4th quarter, HoldingsChannel reports. The fund owned 41,491 shares of the company’s stock after acquiring an additional 3,617 shares during the period. Sei Investments Co.’s holdings in Castle Biosciences were worth $1,106,000 at the end […] - 2025-04-08 07:31:12
Castle Biosciences, Inc. (NASDAQ:CSTL) Shares Bought by Intech Investment Management LLC
Intech Investment Management LLC increased its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 39.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,578 shares of the company’s stock after purchasing an additional 3,294 shares during the quarter. Intech Investment […] - 2025-03-26 08:23:12
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Consensus Rating of “Buy” by Brokerages
Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have earned an average rating of “Buy” from the seven research firms that are covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average 1-year price target among brokerages that have issued ratings on the stock in […] - 2025-03-13 06:20:58
Rhumbline Advisers Reduces Stake in Castle Biosciences, Inc. (NASDAQ:CSTL)
Rhumbline Advisers reduced its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 2.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,892 shares of the company’s stock after selling 1,009 shares during the quarter. Rhumbline Advisers’ holdings in […] - 2025-03-06 09:53:36
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives $40.29 Consensus Target Price from Brokerages
Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have been given a consensus rating of “Buy” by the seven research firms that are presently covering the company, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have covered the stock […] - 2025-02-21 07:11:00
R Squared Ltd Acquires Shares of 1,590 Castle Biosciences, Inc. (NASDAQ:CSTL)
R Squared Ltd acquired a new stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,590 shares of the company’s stock, valued at approximately $42,000. Other institutional investors and […] - 2025-02-03 08:49:05

CSTL institutional holdings

The following institutional investment holdings of CSTL have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 21,770USD 374,662
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 35,558USD 611,953
2025-05-08 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 33,793USD 581,578
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 13,716USD 236,052
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 13,716USD 236,052 0.9%
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 1,251USD 21,530
Total =119,804 USD 2,061,827
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.